EMA

Share Vaccines surveillance and vigilance, collaboration on pregnancy studies and building international patient cohorts were the main topics...

EMA’s human medicines committee (CHMP) has issued an opinion requiring companies to take measures to limit the presence of nitrosamines in human...

Medicines regulatory authorities from around the world have published a report today highlighting the outcomes of the second workshop on...

EMA and the Ministry of Food and Drug Safety of the Republic of Korea (MFDS) have signed an agreement that allows them to share confidential...

Under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA), international regulators discussed COVID-19...

Share The European medicines regulatory network has issued recommendations on impurities in medicines following the conclusion of an exercise to...

The International Coalition of Medicines Regulatory Authorities (ICMRA) convened its regular virtual meeting of regulators from around the world...

EMA has now received an application for conditional marketing authorisation (CMA) of the antiviral medicine remdesivir for the treatment of...

The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a virtual meeting on 3 June 2020. Regular participation in...

The development and availability of medicines and vaccines for all patients in the European Union, including those with COVID-19, is the number...